<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Heart Failure (Prof. Joshi)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-infective-endocarditis-3b.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 28.8%;"></div> <!-- Set percentage dynamically with static value for this chunk -->
                        </div>
                       <span class="progress-text">Lecture 15 of 52</span> <!-- Update text with static value for this chunk -->
                    </div>
                    <a href="cardiology-infective-endocarditis-4.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">HEART FAILURE</h1>
                <p>BY PROF JOSHI</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: definition -->
                <section id="definition" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">DEFINITION</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Abnormality in cardiac structure or function resulting in the inability of the heart to fill with or eject blood at a rate commensurate with the requirements of the metabolizing tissues</li>
                            <li>It is a syndrome characterized by dyspnea. Fatigue and fluid retention</li>
                            <li>It is a progressive disorder of LV remodeling, usually resulting from an index event that culminates in a clinical syndrome characterized by impaired cardiac function and circulatory congestion</li>
                        </ul>
                    </div>
                </section>
                <!-- END: definition -->

                <!-- START: forms-of-hf -->
                <section id="forms-of-hf" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">FORMS OF HEART FAILURE</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Systolic: inability of the ventricles to contract normally and expel sufficient blood</li>
                            <li>Diastolic: HF in patients with preserved systolic function; EF > 50%</li>
                            <li>Due to increased resistance to ventricular inflow -> reduced ventricular diastolic capacity or reduced ventricular relaxation</li>
                            <li>Mostly abnormal or both contraction and relaxation</li>
                        </ul>
                    </div>
                </section>
                <!-- END: forms-of-hf -->

                <!-- START: pathophysiology -->
                <section id="pathophysiology" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">HF PATHOPHYSIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Risk factors</li>
                            <li>Myocardial injury (MI, HTN, VHD, Cardiomyopathy)</li>
                            <li>Initial fall in LV performance - increase wall stress</li>
                            <li>Activation of RAAS and SNS</li>
                            <li>Fibrosis, apoptosis, hypertrophy, cellular and molecular alterations</li>
                            <li>Hemodynamic alterations, salt and water retention -> HF symptoms: dyspnea, edema, fatigue</li>
                            <li>Re-modelling and progressive worsening of LVF -> Morbidity and mortality</li>
                        </ul>
                    </div>
                </section>
                <!-- END: pathophysiology -->

                <!-- START: compensatory-mechanisms -->
                <section id="compensatory-mechanisms" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">COMPENSATORY MECHANISMS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Increase preload - Frank-Starling ventricular dilatation and volume expansion</li>
                            <li>Increase afterload - PV vasoconstriction</li>
                            <li>Hypertrophy - preserve wall stress - Laplace law</li>
                            <li>Salt and water retention - preload</li>
                            <li>Increased HR and myocardial contractility</li>
                            <li>Via neuro-hormonal activation - RAAS. AVP</li>
                        </ul>
                    </div>
                </section>
                <!-- END: compensatory-mechanisms -->

                <!-- START: etiology -->
                <section id="etiology" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">ETIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <p>Categories Six Major: failure related to:</p>
                        <ul>
                            <li>Myocardial abnormalities - myocyte loss etc.</li>
                            <li>External work overload</li>
                            <li>Valvular abnormalities</li>
                            <li>Abnormal cardiac rhythm</li>
                            <li>Pericardial abnormalities</li>
                            <li>Congenital abnormalities</li>
                        </ul>
                    </div>
                </section>
                <!-- END: etiology -->

                <!-- START: epidemiology-kenya -->
                <section id="epidemiology-kenya" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">ADHF EPIDEMIOLOGY KENYA</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Period prevalence hospitalized medical
                                <ul>
                                    <li>KNH 1998 3.3%; 2008 4-6%</li>
                                    <li>Muranga rural 2011 DH 5%</li>
                                </ul>
                            </li>
                            <li>Age: median age KNH 44 year; MDH60 years</li>
                            <li>Prognosis mortality
                                <ul>
                                    <li>In-hospital 11%</li>
                                    <li>Post-discharge 25-37% at 6 months</li>
                                </ul>
                            </li>
                            <li>Re-admission 38%; average 1.3 per patient</li>
                            <li>M&M 49% (40.6 - 57.8)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: epidemiology-kenya -->

                <!-- START: symptomatology -->
                <section id="symptomatology" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">SYMPTOMATOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Cardiac
                                <ul>
                                    <li>Exertional dyspnea</li>
                                    <li>PND; orthopnea</li>
                                    <li>Dyspnea at rest</li>
                                    <li>Palpitations</li>
                                    <li>Leg swelling</li>
                                    <li>Abdominal swelling</li>
                                    <li>RUQ pain</li>
                                </ul>
                            </li>
                            <li>Non-cardiac
                                <ul>
                                    <li>Fatigue</li>
                                    <li>Anorexia</li>
                                    <li>Weight-loss cachexia</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: symptomatology -->

                <!-- START: signs -->
                <section id="signs" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">SIGNS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Systemic venous congestion</li>
                            <li>Pedal edema</li>
                            <li>Tender hepatomegaly</li>
                            <li>Elevated JVP</li>
                            <li>Pulmonary venous congestion</li>
                            <li>Basal rales</li>
                            <li>Hypotension and tachycardia</li>
                            <li>Precordial findings depend on cause</li>
                        </ul>
                    </div>
                </section>
                <!-- END: signs -->

                <!-- START: principles-of-management -->
                <section id="principles-of-management" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PRINCIPLES OF MANAGEMENT</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Diagnosis:
                                <ul>
                                    <li>Presence of HF</li>
                                    <li>Underlying cardiac condition</li>
                                    <li>Precipitating conditions</li>
                                    <li>Comorbidity</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: principles-of-management -->
                
                <!-- START: diagnosis-criteria -->
                <section id="diagnosis-criteria" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Diagnostic Criteria</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">CRITERIA 1 & 2 should be fulfilled in all cases</h3>
                        <ol>
                            <li>Symptoms of HF at rest or on exertion</li>
                            <li>Objective evidence of cardiac dysfunction (at rest)</li>
                        </ol>
                        <h3 class="subsection-heading">IN CASES WHERE THE DIAGNOSIS IS IN DOUBT</h3>
                        <ol start="3">
                            <li>Response to treatment directed towards HF</li>
                        </ol>
                        <h3 class="subsection-heading">MODIFIED FRAMINGHAM CLINICAL CRITERIA FOR THE DIAGNOSIS OF HEART FAILURE</h3>
                        <h4>Major</h4>
                        <ul>
                            <li>PND</li>
                            <li>Orthopnea</li>
                            <li>Elevated JVP</li>
                            <li>Pulmonary rales</li>
                            <li>S3</li>
                            <li>Cardiomegaly on CXR</li>
                            <li>Pulmonary edema on CXR</li>
                            <li>Weight loss</li>
                        </ul>
                        <h4>Minor</h4>
                        <ul>
                            <li>Bilateral leg edema</li>
                            <li>Nocturnal cough</li>
                            <li>Dyspnea on exertion</li>
                            <li>Hepatomegaly</li>
                            <li>Pleural effusion</li>
                            <li>Tachycardia</li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnosis-criteria -->

                <!-- START: diagnosis-algorithm -->
                <section id="diagnosis-algorithm" class="content-section" aria-labelledby="section-heading-11">
                    <h2 id="section-heading-11" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">ALGORITHM FOR THE DIAGNOSIS OF HF</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Suspected HF because of symptoms and signs</li>
                            <li>Assess presence of cardiac diseases by ECG, X-ray or Natriuretic peptides</li>
                            <li>If test is abnormal -> echocardiography</li>
                            <li>If abnormal - assess etiology, HF, precipitating factors and type degree of cardiac dysfunction</li>
                            <li>Additional diagnostic tests where appropriate e.g. coronary angiography</li>
                            <li>Choose therapy</li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnosis-algorithm -->

                <!-- START: investigation -->
                <section id="investigation" class="content-section" aria-labelledby="section-heading-12">
                    <h2 id="section-heading-12" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">INVESTIGATION</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>ECG - normal or high negative predictive value</li>
                            <li>CXR to r/o dyspnea</li>
                            <li>2D echocardiography
                                <ul>
                                    <li>LV dysfunction (systolic/diastolic)</li>
                                    <li>Etiology</li>
                                </ul>
                            </li>
                            <li>Biochemistry and hematology</li>
                            <li>Natriuretic peptides (NT-BNP)</li>
                            <li>Others:
                                <ul>
                                    <li>Stress testing, Holter, catheterization, RNA, MRI</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: investigation -->

                <!-- START: management-aims -->
                <section id="management-aims" class="content-section" aria-labelledby="section-heading-13">
                    <h2 id="section-heading-13" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">MANAGEMENT AIMS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Prevention
                                <ul>
                                    <li>Prevention and/or controlling of diseases leading to cardiac dysfunction and HF</li>
                                    <li>Prevention of progression to HF once cardiac dysfunction is established</li>
                                </ul>
                            </li>
                            <li>Morbidity
                                <ul>
                                    <li>Maintenance or improvement in quality of life</li>
                                </ul>
                            </li>
                            <li>Mortality
                                <ul>
                                    <li>Increased longevity</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: management-aims -->

                <!-- START: management-strategies -->
                <section id="management-strategies" class="content-section" aria-labelledby="section-heading-14">
                    <h2 id="section-heading-14" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">MANAGEMENT STRATEGIES</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Non-pharmacological intervention and lifestyle modification
                                <ul>
                                    <li>Physical activity</li>
                                    <li>Dietary modification</li>
                                    <li>Vaccination - influenza, pneumococcal</li>
                                    <li>Education and counselling</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">CONT.</h3>
                        <ul>
                            <li>Symptomatic therapy
                                <ul>
                                    <li>Diuretic
                                        <ul>
                                            <li>Less signs and symptoms; no mortality benefit; use loop diuretic along with a thiazide (plus a RAAS blocker); monitor renal function</li>
                                        </ul>
                                    </li>
                                    <li>Digoxin
                                        <ul>
                                            <li>Useful in rate control in AF, indicated in: Symptomatic patients after maximal doses in medical treatment and frequent hospitalizations; rate control in AF; large RCTs - no mortality benefit; DIG trial</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">CONT.</h3>
                        <ul>
                            <li>Disease modifying therapy
                                <ul>
                                    <li>Neuro-hormonal interventions:
                                        <ul>
                                            <li>ACE-inhibitors: first line agents, C/I in renal disease, angioedema, persistent cough</li>
                                            <li>Beta-blockers: nebivolol, metoprolol, bisoprolol, carvedilol; provide significant mortality and long-term symptomatic benefit in all grades of HF and post MI-LVSD; start beta blocker in patient free of decompensation.</li>
                                            <li>Aldosterone antagonists: spironolactone, eplerenone; reduced morbidity and mortality in patients with moderate - severe HF; combined with standard ACE-I + BB therapy; watch out for hyperkalemia and tender gynecomastia (spironolactone)</li>
                                            <li>Hydralazine/Nitrate</li>
                                            <li>AT-II receptor antagonists</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                         <h3 class="subsection-heading">CONT.</h3>
                        <ul>
                            <li>Other pharmacological agents</li>
                            <li>Device therapy</li>
                            <li>Surgical options</li>
                        </ul>
                    </div>
                </section>
                <!-- END: management-strategies -->

                <!-- START: drugs-to-avoid -->
                <section id="drugs-to-avoid" class="content-section" aria-labelledby="section-heading-15">
                    <h2 id="section-heading-15" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">DRUGS TO AVOID IN HF</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>NSAIDs - cause fluid retention</li>
                            <li>Rate limiting CCBs - Diltiazem and Verapamil</li>
                            <li>Class I anti-arrhythmics</li>
                            <li>Steroids</li>
                            <li>TCAs</li>
                        </ul>
                        <p>TYPED BY DR. E. NAILA</p>
                    </div>
                </section>
                <!-- END: drugs-to-avoid -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-infective-endocarditis-3b.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 28.8%;"></div>
                        </div>
                       <span class="progress-text">Lecture 15 of 52</span>
                    </div>
                    <a href="cardiology-infective-endocarditis-4.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>